摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-methyl-5-(pyridin-3-yl)thiazol-2-amine

中文名称
——
中文别名
——
英文名称
4-methyl-5-(pyridin-3-yl)thiazol-2-amine
英文别名
2-Amino-4-methyl-5-(3-pyridyl)thiazole;4-methyl-5-pyridin-3-yl-1,3-thiazol-2-amine
4-methyl-5-(pyridin-3-yl)thiazol-2-amine化学式
CAS
——
化学式
C9H9N3S
mdl
MFCD11584506
分子量
191.257
InChiKey
MAVGRLBVTRDWKC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.111
  • 拓扑面积:
    80
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    氰胺 、 3-(3-Methyl-3-nitrooxiran-2-yl)pyridine 在 sodiumsulfide nonahydrate 作用下, 以 丙醇 为溶剂, 反应 8.0h, 以66%的产率得到4-methyl-5-(pyridin-3-yl)thiazol-2-amine
    参考文献:
    名称:
    用于合成取代 2-氨基噻唑的一锅三组分方案
    摘要:
    摘要 由 α-硝基环氧化物、氰胺和硫化钠通过简便、三组分和环保的方案合成了取代的 2-氨基噻唑,收率良好。该反应是在室温下完成的,没有任何添加剂。还提出了一种可能的机制。图形概要
    DOI:
    10.1080/00397911.2017.1350275
点击查看最新优质反应信息

文献信息

  • Efficient and facile strategy to substituted 2-aminothiazoles via ring opening of α-nitroepoxides
    作者:Yue Zhu、Qilin Wang、Haofan Luo、Guolin Zhang、Yongping Yu
    DOI:10.1016/j.tet.2018.09.005
    日期:2018.12
    A novel and efficient reaction has been developed to synthesize a set of substituted 2-aminothiazoles from α-nitroepoxides and ammonium thiocyanate. This reaction could proceed smoothly at mild condition, to afford products for a wide range of substrates with good to excellent yields. A possible mechanism has also been proposed.
    已经开发了一种新颖而有效的反应,以由α-硝基环氧化物硫氰酸铵合成一组取代的2-氨基噻唑。该反应可以在温和的条件下平稳进行,从而以良好或优异的产率提供用于多种底物的产物。还提出了一种可能的机制。
  • Facile, efficient synthesis of polysubstituted thiazoles via α-nitroepoxides and thioureas
    作者:Donghong Zhao、Shanshan Guo、Xiao Guo、Guolin Zhang、Yongping Yu
    DOI:10.1016/j.tet.2016.05.010
    日期:2016.9
    An efficient synthesis of 2,4,5-trisubstituted thiazoles via the reaction of α-nitroepoxides and thioureas under mild conditions has been developed. This reaction proceeded well at room temperature, to afford products in excellent yields for a wide range of substrate, and a possible mechanism has also been proposed.
    已经开发了在温和条件下通过α-硝基环氧化物硫脲反应有效合成2,4,5-三取代噻唑的方法。该反应在室温下进行得很好,从而为广泛的底物提供了具有优异收率的产物,并且还提出了一种可能的机理。
  • Thiazole derivatives and pharmaceutical composition comprising the same
    申请人:Fujisawa Pharmaceutical Co., Ltd.
    公开号:US04649146A1
    公开(公告)日:1987-03-10
    The invention relates to novel pharmaceutical compounds for treatment for ulcer of the formula: ##STR1## wherein R.sup.1 is lower alkyl, carboxy, hydroxymethyl, halomethyl, lower alkylthiomethyl or hydroxyiminomethyl, R.sup.2 is hydrogen, hydroxy, lower alkyl, pyridyl, amino, lower alkylamino, pyridylamino or guanidino optionally substituted with dimethylaminomethylene, R.sup.3 is dihydroisoquinolyl which may be substituted with halogen, lower alkyl, lower alkoxy, carboxy, hydroxy, pyridyl, amino, lower alkylamino, pyridylamino or guanidino, Q is --CO--, and n is an integer of 0 or 1, and pharmaceutically acceptable salts thereof.
    本发明涉及用于治疗溃疡的新型药物化合物,其化学式为:##STR1## 其中,R.sup.1为较低的烷基,羧基,羟甲基,卤代甲基,较低的烷甲基或羟基亚胺甲基;R.sup.2为氢,羟基,较低的烷基,吡啶基,基,较低的烷基基,吡啶基或鸟氨酸基,可选择性地用二甲基基亚甲基取代;R.sup.3为二氢异喹啉基,可以用卤素,较低的烷基,较低的烷氧基,羧基,羟基,吡啶基,基,较低的烷基基,吡啶基或鸟氨酸基取代;Q为--CO--,n为0或1,以及其药学上可接受的盐。
  • Thiazole derivatives, processes for the preparation thereof and
    申请人:Fujisawa Pharmaceutical Co., Ltd.
    公开号:US04735957A1
    公开(公告)日:1988-04-05
    New thiazole derivatives of the formula: ##STR1## wherein R.sup.1 is lower alkyl, carboxy, a drivative of carboxy, hydroxymethyl, halomethyl, lower alkylthiomethyl, hydroxyiminomethyl or alkenyl which may be substituted with lower alkoxycarbonyl, pyridyl or cyano, R.sup.2 is hydrogen, hydroxy, lower alkyl, pyridyl, amino, lower alkylamino, pyridylamino, arylamino, acylamino, N-(lower)alkylN-acylamino, guanidino optionally substituted with dimethylaminomethylene, or ar(lower)alkylamino optionally substituted with lower alkoxy, R.sup.3 is lower alkyl, halo(lower)alkyl or N-containing unsaturated heterocyclic group which may be substituted with halogen, lower alkyl, lower alkoxy, carboxy, a derivative of carboxy, hydroxy, pyridyl, amino, lower alkylamino, pyridylamino, arylamino, acylamino, N-(lower)alkyl-N-acylamino, guanidino, N-oxide or ar(lower)alkylamino optionally substituted with lower alkoxy, Q is --CO--, and n is an integer of 0 or 1, provided that when both of R.sup.1 and R.sup.3 are lower alkyl then n is an integer of 1 and R.sup.2 is lower alkyl, pyridyl, amino, lower alkylamino, pyridylamino, arylamino, acylamino, N-(lower)alkyl-N-acylamino, guanidino optionally substituted with dimethylaminomethylene, or ar(lower)alkylamino optionally substituted with lower alkoxy, and when R.sup.1 is lower alkyl and R.sup.3 is halo(lower)alkyl then n is an integer of 1, and pharmaceutically acceptable salts thereof, and processes for preparation thereof and pharmaceutical composition comprising the same. These derivatives and pharmaceutically acceptable salts thereof are useful as cardiotonic agents and anti-ulcer agents.
    新的噻唑生物化学式为:##STR1## 其中R.sup.1是较低的烷基,羧基,羧基衍生物,羟甲基,卤代甲基,较低的烷基甲基,羟基亚胺甲基或烯基,该烯基可以用较低的烷氧羰基,吡啶基或基取代,R.sup.2为氢,羟基,较低的烷基,吡啶基,基,较低的烷基基,吡啶基,芳基基,酰基基,N-(较低)烷基N-酰基基,瓜二基可选地用二甲氨基甲基取代,或者是可选地用较低的烷氧基取代的ar(较低)烷基基,R.sup.3是较低的烷基,卤代(较低)烷基或含氮的不饱和杂环基,该基可以用卤代,较低的烷基,较低的烷氧基,羧基,羧基衍生物,羟基,吡啶基,基,较低的烷基基,吡啶基,芳基基,酰基基,N-(较低)烷基-N-酰基基,瓜二基,N-氧化物或可选地用较低的烷氧基取代的ar(较低)烷基基取代,Q为--CO--,n为0或1的整数,但当R.sup.1和R.sup.3都是较低的烷基时,n为1的整数,而R.sup.2为较低的烷基,吡啶基,基,较低的烷基基,吡啶基,芳基基,酰基基,N-(较低)烷基-N-酰基基,瓜二基可选地用二甲氨基甲基取代,或者是可选地用较低的烷氧基取代的ar(较低)烷基基,而当R.sup.1为较低的烷基且R.sup.3为卤代(较低)烷基时,n为1的整数,以及其药学上可接受的盐,以及其制备方法和包含其的制药组合物。这些衍生物及其药学上可接受的盐可用作心力衰竭药物和抗溃疡药物。
  • 5-Heteroaryl Thiazoles And Their Use As PI3K Inhibitors
    申请人:Bengtsson Malena
    公开号:US20080132502A1
    公开(公告)日:2008-06-05
    The invention provides thiazole derivatives of formula (I), or pharmaceutically acceptable salts thereof in which Ring A, R 1 , R 2 and R 3 are as defined in the specification; a processes for their preparation; pharmaceutical compositions containing them; and their use in therapy, for example in the treatment of disease mediated by a PI3K enzyme and/or a mTOR kinase.
    本发明提供式(I)的噻唑生物或其药学上可接受的盐,其中环A、R1、R2和R3如说明书中所定义;一种制备它们的方法;含有它们的制药组合物;以及它们在治疗中的用途,例如用于治疗由PI3K酶和/或mTOR激酶介导的疾病。
查看更多